W
BVS icon

WealthCollab’s Bioventus BVS Stock Holding History

WealthCollab’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,702
Closed -$8.97K – 864
2023
Q4 		$8.97K Buy
+1,702
New +$6.74K 0.01% 444

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

WealthCollab's BVS Position: Q1 2024 in Review

WealthCollab sold out of Bioventus (BVS) in Q1 2024, closing a stake of 1,702 shares — an estimated $8.97K sold.

WealthCollab first reported a position in BVS in Q4 2023 and held it in 1 quarter. The position peaked at $8.97K in Q4 2023. 84 funds tracked by Wall St. Rank hold BVS as of Q1 2024.

  • WealthCollab reported no remaining Bioventus position as of Q1 2024 after selling out during the quarter.
  • WealthCollab sold 1,702 Bioventus shares in Q1 2024, an estimated $8.97K.
  • WealthCollab first reported a position in Bioventus in Q4 2023 and held it in 1 quarter.
  • WealthCollab's Bioventus position peaked at $8.97K in Q4 2023.
  • 84 funds tracked by Wall St. Rank held Bioventus as of Q1 2024.

Based on WealthCollab's 13F filing for Q1 2024, filed 10 May 2024.